These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33015411)

  • 1. Identification of twenty-five mutations in surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics.
    Chand GB; Banerjee A; Azad GK
    Gene Rep; 2020 Dec; 21():100891. PubMed ID: 33015411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncovering the impact of SARS-CoV2 spike protein variants on human receptors: A molecular dynamics docking and simulation approach.
    Zaheer M; Ali N; Javed H; Munir R; Jamil N
    J Infect Public Health; 2023 Oct; 16(10):1544-1555. PubMed ID: 37566991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction.
    Nelson-Sathi S; Umasankar PK; Sreekumar E; Nair RR; Joseph I; Nori SRC; Philip JS; Prasad R; Navyasree KV; Ramesh S; Pillai H; Ghosh S; Santosh Kumar TR; Pillai MR
    BMC Mol Cell Biol; 2022 Jan; 23(1):2. PubMed ID: 34991443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
    Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
    Elife; 2021 Aug; 10():. PubMed ID: 34435953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational modeling of the effect of five mutations on the structure of the ACE2 receptor and their correlation with infectivity and virulence of some emerged variants of SARS-CoV-2 suggests mechanisms of binding affinity dysregulation.
    Rodriguez JA; Gonzalez J; Arboleda-Bustos CE; Mendoza N; Martinez C; Pinzon A
    Chem Biol Interact; 2022 Dec; 368():110244. PubMed ID: 36336003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications on its protein structure.
    Chand GB; Banerjee A; Azad GK
    PeerJ; 2020; 8():e9492. PubMed ID: 32685291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding.
    Ahamad S; Kanipakam H; Gupta D
    J Biomol Struct Dyn; 2022 Jan; 40(1):263-275. PubMed ID: 32851910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk.
    Chen P; Wang J; Xu X; Li Y; Zhu Y; Li X; Li M; Hao P
    Comput Biol Chem; 2022 Feb; 96():107613. PubMed ID: 34896769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Spike mutations modify the interaction between virus Spike and human ACE2 receptors.
    Mishra PM; Anjum F; Uversky VN; Nandi CK
    Biochem Biophys Res Commun; 2022 Sep; 620():8-14. PubMed ID: 35772213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taking stock of the mutations in human SARS-CoV-2 spike proteins: From early days to nearly the end of COVID-19 pandemic.
    Guruprasad L; Naresh GK; Boggarapu G
    Curr Res Struct Biol; 2023; 6():100107. PubMed ID: 37841365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of destabilizing SNPs in SARS-CoV2-ACE2 protein and spike glycoprotein: implications for virus entry mechanisms.
    Khalid Z; Naveed H
    J Biomol Struct Dyn; 2022 Feb; 40(3):1205-1215. PubMed ID: 32964802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion.
    Ren W; Ju X; Gong M; Lan J; Yu Y; Long Q; Kenney DJ; O'Connell AK; Zhang Y; Zhong J; Zhong G; Douam F; Wang X; Huang A; Zhang R; Ding Q
    mBio; 2022 Apr; 13(2):e0009922. PubMed ID: 35266815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural stability predictions and molecular dynamics simulations of RBD and HR1 mutations associated with SARS-CoV-2 spike glycoprotein.
    Ahamad S; Hema K; Gupta D
    J Biomol Struct Dyn; 2022 Sep; 40(15):6697-6709. PubMed ID: 33618621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight.
    Khan MI; Khan ZA; Baig MH; Ahmad I; Farouk AE; Song YG; Dong JJ
    PLoS One; 2020; 15(9):e0238344. PubMed ID: 32881907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of SARS-CoV-2 cell entry: insight from
    Gyebi GA; Adegunloye AP; Ibrahim IM; Ogunyemi OM; Afolabi SO; Ogunro OB
    J Biomol Struct Dyn; 2022 Mar; 40(5):2121-2145. PubMed ID: 33089728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
    Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
    Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico analysis of SARS-CoV-2 spike protein N501Y and N501T mutation effects on human ACE2 binding.
    Çubuk H; Özbi L M
    J Mol Graph Model; 2022 Nov; 116():108260. PubMed ID: 35809511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
    Lavie M; Dubuisson J; Belouzard S
    J Virol; 2022 Jul; 96(13):e0047422. PubMed ID: 35678602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coevolutionary forces shaping the fitness of SARS-CoV-2 spike glycoprotein against human receptor ACE2.
    Priya P; Shanker A
    Infect Genet Evol; 2021 Jan; 87():104646. PubMed ID: 33249264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of key point Mutations in Receptor Binding Domain of SARS-CoV-2 Spike Glycoprotein.
    Singh B
    Infect Disord Drug Targets; 2021; 21(4):640-642. PubMed ID: 32753027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.